Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
SYHA1807
/
WuXi AppTec, CSPC Pharma
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
||
||||||||
SYHA1807
/
WuXi AppTec, CSPC Pharma
P1 data, Journal:
Development and validation of a UPLC-MS/MS method for determination of SYHA1807 in a first-in-human study.
(Pubmed Central) - Nov 22, 2023
The established method was fully validated according to bioanalytical guidelines. Results & A rapid, specific
|||
|||||||
SYHA1807
/
WuXi AppTec, CSPC Pharma
New P1 trial:
A Study of SYHA1807 in Subjects With Extensive-Stage Small Cell Lung Cancer
(clinicaltrials.gov) - May 26, 2020
P1
, N=71, Not yet recruiting,
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.